Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Maria Serena Benassi"'
Autor:
Emanuela Palmerini, Laura Pazzaglia, Luca Cevolani, Loredana Pratelli, Michela Pierini, Irene Quattrini, Elisa Carretta, Maria Cristina Manara, Michela Pasello, Giorgio Frega, Anna Paioli, Alessandra Longhi, Marilena Cesari, Rossella Hakim, Toni Ibrahim, Laura Campanacci, Eric Lodewijk Staals, Davide Maria Donati, Maria Serena Benassi, Katia Scotlandi, Stefano Ferrari
Publikováno v:
Cancers, Vol 14, Iss 12, p 2863 (2022)
Background: Giant cell tumors of bone (GCTB) are osteolytic tumors. Denosumab, a RANK-L inhibitor, is approved for GCTB. Data on serum bone turnover marker (sBTM) changes are lacking. We present a phase II correlative study on sBTMs in GCTB patients
Externí odkaz:
https://doaj.org/article/91fc359c9bb94f6c9c1ae5ca81fe085c
Publikováno v:
Veterinary Record Open, Vol 7, Iss 1 (2020)
Background Osteosarcoma (OS) is the most common primary malignant bone tumour in dogs and human beings, characterised by similar genetic and clinical features. With the aim to define similarities and differences in the biological aspects involved in
Externí odkaz:
https://doaj.org/article/759065cc5aa4452ca88c09f5bbfa4569
Autor:
Ymera Pignochino, Federica Capozzi, Lorenzo D’Ambrosio, Carmine Dell’Aglio, Marco Basiricò, Marta Canta, Annalisa Lorenzato, Francesca Vignolo Lutati, Sandra Aliberti, Erica Palesandro, Paola Boccone, Danilo Galizia, Sara Miano, Giulia Chiabotto, Lucia Napione, Loretta Gammaitoni, Dario Sangiolo, Maria Serena Benassi, Barbara Pasini, Giovanna Chiorino, Massimo Aglietta, Giovanni Grignani
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-15 (2017)
Abstract Background Enhancing the antitumor activity of the DNA-damaging drugs is an attractive strategy to improve current treatment options. Trabectedin is an isoquinoline alkylating agent with a peculiar mechanism of action. It binds to minor groo
Externí odkaz:
https://doaj.org/article/e058c6685da841f684afb510424d766a
Autor:
Serena Pollino, Emanuela Palmerini, Barbara Dozza, Elisa Bientinesi, Martina Piccinni-Leopardi, Enrico Lucarelli, Alberto Righi, Maria Serena Benassi, Laura Pazzaglia
Publikováno v:
Journal of Bone Oncology, Vol 17, Iss , Pp - (2019)
Osteosarcoma (OS) is the most frequent primary malignant tumour of bone and metastases occur in 30% of cases, the 5-year survival rate is 25–30%.Although pre- and post-operative chemotherapy has improved prognosis in osteosarcoma (OS), high toxicit
Externí odkaz:
https://doaj.org/article/eaea0a8980ba4f269af9c0ab1cc5e4a0
Autor:
Renata Alleva, Andrea Tognù, Marco Tomasetti, Maria Serena Benassi, Laura Pazzaglia, Hanna van Oven, Ettore Viganò, Nicola De Simone, Ilaria Pacini, Sandra Giannone, Sanjin Gagic, Raffaele Borghi, Sara Picone, Battista Borghi
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219113 (2019)
ObjectivesTo investigate the modulation of genes whose expression level is indicative of stress and toxicity following exposure to three anaesthesia techniques, general anaesthesia (GA), regional anaesthesia (RA), or integrated anaesthesia (IA).Metho
Externí odkaz:
https://doaj.org/article/78733488c7a246a5b817eaeef4670210
Autor:
Leonardo Leonardi, Katia Scotlandi, Ilaria Pettinari, Maria Serena Benassi, Ilaria Porcellato, Laura Pazzaglia
Publikováno v:
Cells, Vol 10, Iss 2, p 428 (2021)
Osteosarcoma (OS) is the most frequent primary malignant tumor of bone in humans and animals. Comparative oncology is a field of study that examines the cancer risk and tumor progression across the species. The canine model is ideally suited for tran
Externí odkaz:
https://doaj.org/article/17f69358fa2043f583f8c8e5ebb5f056
Autor:
Peter Balla, Mate Elod Maros, Gabor Barna, Imre Antal, Gergo Papp, Zoltan Sapi, Nicholas Anthony Athanasou, Maria Serena Benassi, Pierro Picci, Tibor Krenacs
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125316 (2015)
Missense mutations of the GJA1 gene encoding the gap junction channel protein connexin43 (Cx43) cause bone malformations resulting in oculodentodigital dysplasia (ODDD), while GJA1 null and ODDD mutant mice develop osteopenia. In this study we invest
Externí odkaz:
https://doaj.org/article/9837752ac8ae40519dc371554aa2c64f
Autor:
Chiara Novello, Laura Pazzaglia, Amalia Conti, Irene Quattrini, Serena Pollino, Paola Perego, Piero Picci, Maria Serena Benassi
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114757 (2014)
Osteosarcoma (OS) is the most common primary malignant bone tumor and prevalently occurs in the second decade of life. Etoposide, a chemotherapeutic agent used in combined treatments of recurrent human OS, belongs to the topoisomerase inhibitor famil
Externí odkaz:
https://doaj.org/article/9fb3b57677004b2c95fc37a6ba4d5d1c
Autor:
Teresa González-Muñoz, Angela Di Giannatale, Susana García-Silva, Vanesa Santos, Sara Sánchez-Redondo, Claudia Savini, Osvaldo Graña-Castro, Carmen Blanco-Aparicio, David J Pisapia, Jose L Rodríguez-Peralto, Cleofé Romagosa Pérez-Portabella, Rita Alaggio, Maria Serena Benassi, Laura Pazzaglia, Katia Scotlandi, Nancy Ratner, Kaleb Yohay, Charles P. Theuer, Héctor Peinado
PurposeMalignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive softtissue sarcomas that lack effective treatments, underscoring the urgent need to uncover novel mediators of MPNST pathogenesis that may serve as potential therapeutic t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74e907983ce72efacb7197aa3a82110e
https://doi.org/10.1101/2022.08.12.503580
https://doi.org/10.1101/2022.08.12.503580
Autor:
Poosit Ruengwanichayakun, Davide Maria Donati, Luca Sangiorgi, Elena Pedrini, Andrea Sambri, Laura Pazzaglia, Giuseppe Bianchi, Alberto Righi, Maria Serena Benassi
Publikováno v:
Virchows Archiv. 476:445-454
Solitary fibrous tumor is a rare mesenchymal neoplasm that exhibits a broad spectrum of biological behaviors. Few studies relative to clinical-pathologic features and predictive factors have been reported, all involving a mixed population of tumors o